Hanseatic Management Services’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-12
Closed -$2K 233
2019
Q3
$2K Hold
12
﹤0.01% 185
2019
Q2
$3K Hold
12
﹤0.01% 180
2019
Q1
$2K Buy
+12
New +$2.25K ﹤0.01% 235
2017
Q1
Sell
-11
Closed -$2K 401
2016
Q4
$2K Hold
11
﹤0.01% 271
2016
Q3
$3K Buy
+11
New +$2.43K ﹤0.01% 238
2014
Q3
Sell
-160
Closed -$42K 336
2014
Q2
$42K Buy
+160
New +$34.9K 0.03% 139

Other funds holding AXDX

Hanseatic Management Services's AXDX Position: Q4 2019 in Review

Hanseatic Management Services sold out of Accelerate Diagnostics (AXDX) in Q4 2019, closing a stake of 12 shares — an estimated $2K sold.

Hanseatic Management Services first reported a position in AXDX in Q2 2014 and held it in 6 quarters. The position peaked at $42K in Q2 2014. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2019.

  • Hanseatic Management Services reported no remaining Accelerate Diagnostics position as of Q4 2019 after selling out during the quarter.
  • Hanseatic Management Services sold 12 Accelerate Diagnostics shares in Q4 2019, an estimated $2K.
  • Hanseatic Management Services first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 6 quarters.
  • Hanseatic Management Services's Accelerate Diagnostics position peaked at $42K in Q2 2014.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2019.

Based on Hanseatic Management Services's 13F filing for Q4 2019, filed 29 Jan 2020.